|Articles|October 4, 2022
Almac Announces New Cryogenic Service Solution
New solution within Durham, North Carolina campus will support cell and gene therapies.
Advertisement
Almac Clinical Services announced a new Cryogenic Service Solution within its Durham, North Carolina campus to support cell and gene therapies.
This latest investment from Almac adds to the company’s overall $4m investment to date in innovative cold chain technology in North Carolina.
Read more about the new solution
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
Generative AI Transforms Clinical Study Report DevelopmentSeptember 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Generative AI Transforms Clinical Study Report Development
2
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
3
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
4
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
